GGrantIndex
← Leaderboards

Scott O Zeitlin

University Of Virginia

$8,386,162
Attributed
$8,386,162
Total exposure
6
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $691.3K · FY200525
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$8,386,162 · 6

By mechanism

R01$7,621,787 · 4
R21$423,500 · 1
R56$340,875 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Virginia

Same institution · by research overlap

Others in their field

Top investigators on “Phenotype

Research focus

PhenotypePathogenesisNeurodegenerative DisordersMutantPolyglutamineMouse ModelAllelesStretchingGenesHuntington DiseaseTrinucleotide RepeatsAffectBehavioralCorpus Striatum StructureGene ExpressionBasePathway InteractionsGain Of FunctionProteinsDisease ModelNeuronsBrainExhibitsNeuropathology

Grant awards (25)

Understanding the mechanisms that modulate the effects of mutant Huntingtin lowering in aging Huntington's disease model mice$415,021
R01 · FY2025 · NS · contact PI
Understanding the mechanisms that modulate the effects of mutant Huntingtin lowering in aging Huntington's disease model mice$402,571
R01 · FY2024 · NS · contact PI
Understanding the mechanisms that modulate the effects of mutant Huntingtin lowering in aging Huntington's disease model mice$415,021
R01 · FY2023 · NS · contact PI
Understanding the mechanisms that modulate the effects of mutant Huntingtin lowering in aging Huntington's disease model mice$415,021
R01 · FY2022 · NS · contact PI
Modeling the effects of reducing huntingtin and Hdh alternative splicing in mice$345,625
R01 · FY2018 · NS · contact PI
Huntingtin proline-rich region modulation of Huntington's disease pathogenesis$345,625
R01 · FY2018 · NS · contact PI
Huntingtin proline-rich region modulation of Huntington's disease pathogenesis$345,625
R01 · FY2017 · NS · contact PI
Modeling the effects of reducing huntingtin and Hdh alternative splicing in mice$345,625
R01 · FY2017 · NS · contact PI
Huntingtin proline-rich region modulation of Huntington's disease pathogenesis$345,625
R01 · FY2016 · NS · contact PI
Modeling the effects of reducing huntingtin and Hdh alternative splicing in mice$345,625
R01 · FY2016 · NS · contact PI
Huntingtin proline-rich region modulation of Huntington's disease pathogenesis$345,625
R01 · FY2015 · NS · contact PI
Modeling the effects of reducing huntingtin and Hdh alternative splicing in mice$345,625
R01 · FY2015 · NS · contact PI
Huntingtin proline-rich region modulation of Huntington's disease pathogenesis$345,625
R01 · FY2014 · NS · contact PI
Loss-of-function mechanisms in Huntington's Disease$318,583
R01 · FY2013 · NS · contact PI
Loss-of-function mechanisms in Huntington's Disease$330,138
R01 · FY2012 · NS · contact PI
Reversible conditional models for Huntington's disease$192,500
R21 · FY2012 · NS · contact PI
Loss-of-function mechanisms in Huntington's Disease$327,958
R01 · FY2011 · NS · contact PI
Reversible conditional models for Huntington's disease$231,000
R21 · FY2011 · NS · contact PI
Loss-of-function mechanisms in Huntington's Disease$334,853
R01 · FY2010 · NS · contact PI
Loss-of-function mechanisms in Huntington's disease$340,875
R56 · FY2008 · NS · contact PI
Loss-of-function mechanisms in Huntington's disease$299,958
R01 · FY2007 · NS · contact PI
Loss-of-function mechanisms in Huntington's disease$308,916
R01 · FY2006 · NS · contact PI
Loss-of-function mechanisms in Huntington's disease$316,350
R01 · FY2005 · NS
Loss-of-function mechanisms in Huntington's disease$316,350
R01 · FY2004 · NS
Loss-of-function mechanisms in Huntington's disease$310,422
R01 · FY2003 · NS